--- the subscriber area has no ads and those above are not selected or endorsed by this site ---
Ebix 3Q20 results +3
12:01 09-Nov-20
The Ebix conference call is ongoing in typically long-winded
fashion. Although the CEO personally lost his mother to the
pandemic and had two sisters in the ICU, he still uses phrases
like, "Once the COVID-19 impact subsides in 2021...", and "we're
keeping our fingers crossed" with regard to EbixCash IPO, "until
the impact ... blows over." I would agree with him that India
remains a key investment market, with plenty of interest.
However, I have to reiterate that time of the essence for Ebix,
and add that many of the effects that management is characterizing
as temporary may be sustained. For instance, electronic payment
solutions have lower margins for Ebix than other products. The
company is also benefiting from rent reductions at airports, and I
question whether or not those reductions will outlast a decline in
travel, especially given my notes on vaccine availability in early
2021.
- Overall revenue down 7% YtD
- Cash on the balance sheet decreased ~20%
- Current Liabilities and Long Term Debt both increased
significantly.
Ebix has reported its third quarter results:
EBIX is up almost 8% in the pre-market to just under $21, and the move looks sustainable to me, despite the lack of guidance. Samsung is moving ahead with plans to shift its AMOLED production from China to India with the newest plant to open by the middle of next year. EbixCash is still being impacted by the pandemic though and there is no word on IPO plans. Thus, while I was willing to take a chance on EBIX ahead of earnings, I'm not willing to chase it at this point. The conference call is at 11am and I may or may not write further depending on what I hear.
- 93 cents of EPS beats by 12 cents
- from $154.3M of revenue, which beats by $35.3M
- still declining to provide guidance